Purpose With prospective clinical sequencing of tumors emerging as a mainstay in cancer
care, an urgent need exists for a clinical support tool that distills the clinical implications …

… SEER releases new research data each spring based on the previous November’s data …
S herein (previously reported distributions are available in older versions of this paper). …

BACKGROUND Survivors of head and neck squamous cell carcinoma (HNSCC) face excess
mortality from multiple causes. METHODS We used the population‐based Surveillance, …

Importance Recurrent and/or metastatic head and neck cancer is usually incurable.
Implementation of precision oncology for these patients has been limited by incomplete …

Context BRAF V600E mutant thyroid cancers are often refractory to radioiodine (RAI).
Objectives To investigate the utility and molecular underpinnings of enhancing lesional iodide …

BACKGROUND: Second primary malignancies (SPMs) are the leading cause of death in
survivors of head and neck squamous cell carcinoma (HNSCC). Synchronous SPMs are of …

BACKGROUND There has been increasing interest in the primary surgical treatment of
patients with early T classification (T1‐T2) oropharyngeal squamous cell carcinoma (OPSCC), …

Background: Oncogenic activation of mitogen-activated protein kinase (MAPK) signaling is
associated with radioiodine refractory (RAIR) thyroid cancer. Preclinical models suggest that …

Eighteen percent of incident malignancies in the United States are a second (or subsequent)
cancer. Second primary neoplasms (SPNs), particularly solid tumors, are a major cause of …

BACKGROUND The Institute of Medicine recommended that survivors of cancer and their
primary care providers receive survivorship care plans (SCPs) to summarize cancer treatment …